user

Prognostic value of DNA cytometry in patients with non-small cell lung carcinoma

被引：0
|
作者：
Skuballa, A [1 ]
Starke, U [1 ]
Achatzy, R [1 ]
Hutschenreiter, J [1 ]
机构：
[1] Stadt Klinikum St Georg, Klin Thoraxchirurg, Leipzig, Germany
来源：
6TH EUROPEAN CONFERENCE ON GENERAL THORACIC SURGERY | 1998年
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
DNA flow cytometry;was used to study ploidy and cell cycle phase in patients with non - small cell lung carcinoma. A total number of 80 tumor samples were investigated. Cell cycle analysys was possible in 42 tumors. 79% of the tumors were aneuploid and 21% had diploid tumors. There was a correlation between high S-phase fraction in aneuploid tumors and lower S-phase fraction in diploid tumors. Patients with a lower S-phase fraction had a tendency to better survival, both diploid and aneuploid tumors.
引用
收藏
页码：89 / 92
页数：4
相关论文
共 50 条
  • [21] PROGNOSTIC VALUE OF THE PROTEIC EXPRESSION PROFILE IN LOCALLY ADVANCED NON-SMALL CELL LUNG CARCINOMA
    Morbeck, Igor P.
    Gross, Jefferson L.
    Andrade, Victor
    Fogaroli, Ricardo
    Haddad, Fabio
    Younes, Riad
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S949 - S949
  • [22] The prognostic value of intraepithelial and stromal innate immune cells in non-small cell lung carcinoma
    Al-Shibli, K.
    Al-Saad, S.
    Donnem, T.
    Persson, M.
    Bremnes, R.
    Busund, L.
    HISTOPATHOLOGY, 2008, 53 : 337 - 337
  • [23] Prognostic value of microRNA expression in operable non-small cell lung cancer patients
    Skrzypski, M.
    Czapiewski, P.
    Goryca, K.
    Jassem, E.
    Wyrwicz, L.
    Pawlowski, R.
    Rzyman, W.
    Biernat, W.
    Jassem, J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 991 - 1000
  • [24] Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Kim, Anthony W.
    Batus, Marta
    Myint, Ronald
    Fidler, Mary J.
    Basu, Sanjib
    Bonomi, Philip
    Faber, L. Penfield
    Wightman, Sean C.
    Warren, William H.
    McIntire, Maria
    Arvanitis, Leonidas D.
    Gattuso, Paolo
    Xue, Xiulong
    Liptay, Michael J.
    LUNG CANCER, 2011, 71 (02) : 186 - 190
  • [25] Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer
    Xu, Chun-Hua
    Wang, Wei
    Lin, Yong
    Qian, Li-Hua
    Zhang, Xiu-Wei
    Wang, Qing-Bo
    Yu, Li-Ke
    ONCOTARGET, 2017, 8 (12) : 18746 - 18753
  • [26] Prognostic value of microRNA expression in operable non-small cell lung cancer patients
    M Skrzypski
    P Czapiewski
    K Goryca
    E Jassem
    L Wyrwicz
    R Pawłowski
    W Rzyman
    W Biernat
    J Jassem
    British Journal of Cancer, 2014, 110 : 991 - 1000
  • [27] The prognostic value of Serum Cripto-1 in patients with non-small cell lung
    Haggag, R. M.
    El-Shorbagy, S.
    Ebian, H. F.
    Labib, H. A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
    Nygaard, Anneli Dowler
    Spindler, Karen-Lise Garm
    Pallisgaard, Niels
    Andersen, Rikke Fredslund
    Jakobsen, Anders
    LUNG CANCER, 2013, 79 (03) : 312 - 317
  • [29] Cell-free tumour DNA as a diagnostic and prognostic biomarker in non-small cell lung carcinoma
    Lochowska, Barbara
    Nowak, Dariusz
    Bialasiewicz, Piotr
    ADVANCES IN RESPIRATORY MEDICINE, 2019, 87 (02) : 118 - 122
  • [30] Prognostic significance of leucocytosis in patients with metastatic non-small cell lung carcinoma.
    Ameadour, Lamiae
    Benbrahim, Zineb
    Ziani, Fatima Zahra
    Boudahna, Lamlae
    Sy, Osmane
    Arifi, Samia
    Mellas, Nawfel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345